Contact the team
The PREDNOS 2 trial team are always here to help. For further information about the PREDNOS 2 trial please contact us:
For general queries about the study, site set-up and queries about collection of data and data anaylsis please contact the Birmingham Clinical Trials Unit.
PREDNOS 2 Trial Office
Birmingham Clinical Trials Unit (BCTU)
Institute of Applied Health Research
College of Medical and Dental Sciences
Public Health Building
University of Birmingham
Birmingham B15 2TT
PREDNOS 2 trial staff:
Elizabeth Brettell Trials Manager 0121 415 9130
Emma Barsoum Trial Co-ordinator 0121 415 9132
Noreen Akhtar Trials Administrator 0121 415 9134
Charmaine Hunt Trial Administrator 0121 415 9132
Terry Hughes Data Manager 0121 415 9131
Adam Khan Data Manager 0121 415 9131
Find out more information about our other renal trials
The University of Birmingham Clinical Trials Unit (BCTU) is a Research Unit in the School of Medicine specialising in the design, conduct and analysis of clinical trials.
Accuracy of glomerular filtration rate (GFR) estimation using creatinine and cystatin C and albuminuria for monitoring disease progression in patients with stage 3 chronic kidney disease: prospective longitudinal study in a multi-ethnic population.
Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis: an international randomised controlled trial.
Long-term tapering versus standard prednisolone (steroid) therapy for the treatment of the initial episode of childhood nephrotic syndrome: national multicentre randomised double blind trial
STOP-ACEi is a multi-centre, randomised controlled trial of Angiotensin Converting Enzyme inhibitor (ACEi) / Angiotensin Receptor Blocker (ARB) withdrawal in advanced kidney disease.
Eculizumab in Shiga-Toxin producing E. Coli Haemolytic Uraemic Syndrome (ECUSTEC): A Randomised, Double Blind, Placebo-Controlled Trial.